Groowe Groowe / Newsroom / NVS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVS News

Novartis AG

Stomach Cancer Market Insights, Trends and Innovations Worldwide, 2026-2030 & 2035

globenewswire.com
PFE MRK SNY BMY AZN NVS ASRT GSK

Low-Grade Glioma Market Trends and Investment Opportunities Through 2030 & 2035: Regional Insights for Trametinib, Dabrafenib, Ivosidenib, and Mirdametinib

globenewswire.com
DAY NVS AZN

Medulloblastoma Drugs Market Analysis and Growth Forecast 2026-2030 & 2035 by Drug Candidate, Product, Route of Administration, Distribution Channel, End-user and Region

globenewswire.com
PFE NVS BMY MRK AZN

Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight

globenewswire.com
BIIB NVS VTRS UCB BMY ABBV AZN CABA AUR GSK VERA KYMR NKTR VRTX ARWR

Rinck Advertising and Novonesis Earn Silver ADDY Award for Illustration from AAF Baltimore

globenewswire.com
NVS

Advanced Renal Cell Carcinoma Treatment Market to Grow by $3.1 Billion During 2026-2030: Global Industry Assessment Featuring Pfizer, Merck & Co., Bristol-Myers Squibb, AstraZeneca, Novartis and More

globenewswire.com
MRK EXEL PFE BMY AZN NVS

Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry

globenewswire.com
PFE NVS EXEL BMY AMRX JNJ

Heart Risks Go Beyond the Heart: Don’t Forget to Check Blood Sugar and Kidney Health

globenewswire.com
NVO NVS DVA

Chemotherapy Market to Hit $20.99 Billion by 2035, Driven by Rising Cancer Incidence – SNS Insider

globenewswire.com
NVS PFE

Carcinoid Tumor Market to Rise at 10.1% CAGR During 2026-2030: Increasing Obesity Rates Spur Growth

globenewswire.com
TMO MRK PFE NVS